[1] KALRA S, AGGARWAL S, KHANDELWAL D. Thyroid dysfunction and type 2 diabetes mellitus: screening strategies and implications for management [J]. Diabetes Ther, 2019, 10(6): 2035-2044. [2] ISSA C M. Vitamin D and type 2 diabetes mellitus [J]. Adv Exp Med Biol, 2017, 996: 193-205. [3] YUAN X Y, WANG X G. Mild cognitive impairment in type 2 diabetes mellitus and related risk factors: a review [J]. Rev Neurosci, 2017, 28(7): 715-723. [4] ARNOLD S E, ARVANITAKIS Z, MACAULEY-RAMBACH S L, et al. Brain insulin resistance in type 2 diabetes and Alzheimer disease: concepts and conundrums [J]. Nat Rev Neurol, 2018, 14(3): 168-181. [5] SAMPATH KUMAR A, MAIYA A G, SHASTRY B A, et al. Exercise and insulin resistance in type 2 diabetes mellitus: a systematic review and meta-analysis [J]. Ann Phys Rehabil Med, 2019, 62(2): 98-103. [6] REHMAN K, AKASH M S H, LIAQAT A, et al. Role of interleukin-6 in development of insulin resistance and type 2 diabetes mellitus [J]. Crit Rev Eukaryot Gene Expr, 2017, 27(3): 229-236. [7] JEBUR H B, MASROOR M, AHMAD H, et al. CRP gene polymorphism and their risk association with type 2 diabetes mellitus [J]. Open Access Maced J Med Sci, 2018, 7(1): 33-37. [8] RIBEIRO I S, PEREIRA Í S, SANTOS D P, et al. Association between body composition and inflammation: a central role of IL-17 and IL-10 in diabetic and hypertensive elderly women [J]. Exp Gerontol, 2019, 127: 110734. [9] JIANG L Q, FRANCK N, EGAN B, et al. Autocrine role of interleukin-13 on skeletal muscle glucose metabolism in type 2 diabetic patients involves microRNA let-7 [J]. Am J Physiol Endocrinol Metab, 2013, 305(11): E1359-E1366. [10]SACERDOTE A, DAVE P, LOKSHIN V, et al. Type 2 diabetes mellitus, insulin resistance, and vitamin D [J]. Curr Diab Rep, 2019, 19(10): 101. |